Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
2801	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2020	Standard Therapy	Germany	51
2802	Apheresis	Allogeneic	Dyskeratosis Congenita	Hematology	2020	Standard Therapy	Poland	19
2803	Apheresis	Allogeneic	Erdheim-Chester Disease	Hematology	2020	Standard Therapy	Poland	4
2804	Apheresis	Autologous	Ewing Sarcoma	Hematology	2020	Standard Therapy	Germany	30
2805	Apheresis	Allogeneic	Fanconi Anemia	Hematology	2020	Standard Therapy	Poland	1
2806	Apheresis	Allogeneic	Fanconi Anemia	Hematology	2020	Standard Therapy	Poland	29
2807	Apheresis	Autologous	Germ Cell Tumor	Hematology	2020	Standard Therapy	Germany	30
2808	Apheresis	Autologous	Hodgkin Lymphoma	Hematology	2020	Standard Therapy	Germany	48
2809	Apheresis	Autologous	Hodgkin Lymphoma	Hematology	2020	Standard Therapy	Germany	22
2810	Apheresis	Autologous	Hodgkin Lymphoma-Relapse	Hematology	2020	Standard Therapy	Germany	66
2811	Apheresis	Allogeneic	Lymphoblastic Lymphoma	Hematology	2020	Standard Therapy	Poland	24
2812	Apheresis	Allogeneic	Mantle Cell Lymphoma	Hematology	2020	Standard Therapy	Poland	56
2813	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2020	Standard Therapy	Germany	56
2814	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2020	Standard Therapy	Germany	48
2815	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2020	Standard Therapy	Germany	53
2816	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2020	Standard Therapy	Germany	59
2817	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2020	Standard Therapy	Germany	65
2818	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2020	Standard Therapy	Germany	58
2819	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2020	Standard Therapy	Germany	49
2820	Apheresis	Allogeneic	Mast Cell Leukemia	Hematology	2020	Standard Therapy	Germany	55
2821	Apheresis	Autologous	Morbus Hodgkin	Hematology	2020	Standard Therapy	Germany	68
2822	Apheresis	Autologous	Morbus Hodgkin	Hematology	2020	Standard Therapy	Germany	53
2823	Apheresis	Autologous	Morbus Hodgkin-Relapse	Hematology	2020	Standard Therapy	Germany	18
2824	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	54
2825	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	66
2826	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	56
2827	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	65
2828	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	70
2829	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	41
2830	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	56
2831	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	61
2832	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	55
2833	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	67
2834	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	52
2835	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	69
2836	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	64
2837	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	46
2838	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	55
2839	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	60
2840	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	65
2841	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	51
2842	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	55
2843	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	63
2844	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	65
2845	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	55
2846	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	65
2847	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	68
2848	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	65
2849	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	42
2850	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	59
2851	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	66
2852	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	65
2853	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	67
2854	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	65
2855	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	60
2856	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	68
2857	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	63
2858	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	68
2859	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	63
2860	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	62
2861	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	49
2862	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	45
2863	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	65
2864	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	45
2865	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	66
2866	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	40
2867	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	53
2868	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	54
2869	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	44
2870	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	68
2871	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	48
2872	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	68
2873	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	66
2874	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	68
2875	Apheresis	Autologous	Multiple Myeloma	Hematology	2020	Standard Therapy	Germany	54
2876	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	67
2877	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	59
2878	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	60
2879	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	62
2880	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	55
2881	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	70
2882	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	66
2883	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	51
2884	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	56
2885	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	64
2886	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	63
2887	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	73
2888	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	63
2889	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	37
2890	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	59
2891	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	70
2892	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	74
2893	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	66
2894	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	22
2895	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	64
2896	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	70
2897	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	70
2898	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	67
2899	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	60
2900	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2020	Standard Therapy	Poland	68

Previous

Page 29 of 72 1 27 28 29 30 31 72

Next